Altaïr Avocats·
We are only able to display limited information for this firm. We display more complete information for all of the following firms:
Altaïr Avocats·'s practice is particularly recognised for its work in the biotech, pharma, energy transition, and healthtech segments. The practice advises both growth-stage companies and venture capital funds on capital raisings, deal structuring and governance matters. Philippe Beauregard excels across the full range of capital investments, M&A, and joint ventures, while Pierre Gramage supports venture capital clients from creation to final exit.
\n
\n
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
- ‘An extremely agile, available, supportive, patient, and highly skilled team, attentive to detail. Works tirelessly to find solutions that best meet the expectations of all stakeholders.’
- ‘I work mainly with Philippe Beauregard. Qualities: deal maker, responsive, competent.’
Key clients
- Demeter
- Andera Partners
Work highlights
Advised Crédit Mutuel Impact on the €16m Series A financing of Eco-Tech Ceram, a company specialising in energy efficiency technologies.